Literature DB >> 10682906

Gene transfer into the CNS using recombinant adeno-associated virus: analysis of vector DNA forms resulting in sustained expression.

K R Clark1, T J Sferra, W Lo, G Qu, R Chen, P R Johnson.   

Abstract

Recombinant adeno-associated virus (rAAV) vectors have shown significant promise as vehicles for in vivo gene transfer, particularly for transduction of organs composed primarily of non-dividing cells (i.e., muscle, CNS, and liver). However, the mechanistic basis for this desirable property remains unclear. To investigate the fate of rAAV genomes in mouse brain, we stereotactically injected an rAAV vector carrying the E. coli lacZ gene into the caudate of BALB/c mice and demonstrate efficient transduction of mouse brain cells that possess cellular morphology consistent with post-mitotic neurons. We observed a significant increase in beta-galactosidase expression from 5 to 56 days after injection that paralleled the disappearance of single-stranded DNA input genomes. Analysis of in vivo viral DNA forms over time out to 5 months after inoculation revealed that rAAV genomes associated with high molecular weight mouse chromosomal DNA by 14 days after injection and persisted for the length of this study. The pattern of Southern hybridization was consistent with random viral integration in predominantly head-to-tail concatameric arrays. Importantly, we also documented an additional DNA species that appears to be a monomeric episomal circular form based on nuclease sensitivity assays. These data are the first to document the existence of multiple vector DNA forms present within the adult murine brain following direct rAAV inoculation and therefore, provide insight into the molecular events that ultimately result in long-term rAAV mediated transgene expression.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10682906     DOI: 10.3109/10611869909085510

Source DB:  PubMed          Journal:  J Drug Target        ISSN: 1026-7158            Impact factor:   5.121


  6 in total

1.  Genetic fate of recombinant adeno-associated virus vector genomes in muscle.

Authors:  Bruce C Schnepp; K Reed Clark; Dori L Klemanski; Christina A Pacak; Philip R Johnson
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

Review 2.  The promise of gene therapy in gastrointestinal and liver diseases.

Authors:  J Prieto; M Herraiz; B Sangro; C Qian; G Mazzolini; I Melero; J Ruiz
Journal:  Gut       Date:  2003-05       Impact factor: 23.059

3.  Characterization of adeno-associated virus genomes isolated from human tissues.

Authors:  Bruce C Schnepp; Ryan L Jensen; Chun-Liang Chen; Philip R Johnson; K Reed Clark
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

4.  Knockdown and overexpression of NR1 modulates NMDA receptor function.

Authors:  Maggie L Kalev-Zylinska; Wymond Symes; Deborah Young; Matthew J During
Journal:  Mol Cell Neurosci       Date:  2009-04-24       Impact factor: 4.314

Review 5.  Gene therapy: recombinant adeno-associated virus vectors.

Authors:  J R Smith-Arica; J S Bartlett
Journal:  Curr Cardiol Rep       Date:  2001-01       Impact factor: 3.955

6.  Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN.

Authors:  Kevin D Foust; Xueyong Wang; Vicki L McGovern; Lyndsey Braun; Adam K Bevan; Amanda M Haidet; Thanh T Le; Pablo R Morales; Mark M Rich; Arthur H M Burghes; Brian K Kaspar
Journal:  Nat Biotechnol       Date:  2010-02-28       Impact factor: 68.164

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.